A Los Angeles judge set further dates on Friday to discuss the remand from federal court of a state lawsuit accusing prominent pharmaceutical companies and pharmacy benefit managers, including Eli Lilly and CVS, of artificially inflating the cost of insulin.
Judge David S. Cunningham III set a tentative date of June 24 to discuss the status of the remand.
"My practice is to at least have a placeholder, so I would set this for six months out, and if something happens ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In